HomeOpen Access NewsPharmaceutical Industry

Pharmaceutical Industry

NPA analysis finds over 6 million hours spent in A&E on cases treatable by community pharmacies

A new report by the National Pharmacy Association reveals that patients spent over 6 million hours in A&E last year for minor health issues that could have been managed by community pharmacies, highlighting an opportunity to ease pressure on emergency services.

From Cannabis flower to final products: Extractions for Phytopharmaceuticals

Dr Nikos Xynos, PhD in Pharmaceutical Sciences/Natural Products Chemistry and MD a Nomad Labs, explores the various pathways to cannabinoid extraction, refining and purification technologies.

Medicinal cannabis: What the UK can learn from Denmark

Spectrum Therapeutics UK lifts the lid here on a pilot analysis of medicinal cannabis use that will run in Denmark until January 2022.

SSPC: Training the next generation of highly skilled pharmaceutical scientists and engineers

Louise O’Neill from SSPC, the SFI Research Centre for Pharmaceuticals, underlines the importance of training the next generation of highly skilled pharmaceutical scientists and engineers in Ireland.

The value of accreditation in the cannabis industry

Chris Gunning, General Manager – Accreditation Services at A2LA, discusses the value of accreditation in today’s cannabis industry.

Data science: Providing medication and creating a more efficient NHS

Rich Pugh, Chief Data Scientist at Mango Solutions, discusses how data science can be used for good, with a particular focus on the provision of medication and helping create a more efficient NHS.

NHS could save £651 million with community pharmacy service

Researchers have assessed a community pharmacy service and calculated that this would save the NHS around £651 million.

Cystic fibrosis drugs agreement secured by NHS England

NHS England has announced it has secured a definitive cystic fibrosis drugs agreement with Vertex Pharmaceuticals, to use all three of their UK-licensed medicines.

New Electronic Prescription Service could save NHS £300 million

The NHS could save £300 million over the next 3 years as Phase 4 of the Electronic Prescription Service (EPS) is rolled out across the country.

Medical devices policy: Japan’s Ministry of Health, Labour and Welfare

Here, we look at medical devices policy of Japan’s Ministry of Health, Labour and Welfare. The Ministry now has Katsunobu Katō in place, who very recently replaced Nemoto Takumi as the Minister of Health, Labour and Welfare in the country.

Access to medical cannabis and to what extent is medical cannabis now legalised?

Cosmo Feilding Mellen, Managing Director of Spectrum Therapeutics UK looks at access to medical cannabis and to what extent is medical cannabis now legalised.

Swansea University Medical School’s Director of Research releases 100th cancer research paper

After a career spanning more than 20 years, a Swansea University Professor’s passion for research is as ‘strong as ever’, as he marks a very notable achievement – the release of his 100th cancer research paper.

Getting your chemistry right

Prof Colin J Suckling OBE DSc FRSE from the Department of Pure & Applied Chemistry, at University of Strathclyde, explains the importance of getting your chemistry right.

Academia: An important player in the drug discovery ecosystem

Dr Richard Angell and Dr Jane Kinghorn from the Drug Discovery Group (Translational Research Office), at University College London (UCL), explain the value of drug discovery in academia in bridging the “Valley of Death”.

SSPC investing in future innovation for the pharmaceutical sector

SSPC, the Science Foundation Ireland Research Centre for Pharmaceuticals, explains how they are recognised internationally as a hub of process innovation and advanced manufacturing for the pharmaceutical sector.

Pharmacy education set to thrive at Swansea University

Swansea University is taking action to build on the increasingly important role of the pharmacist in healthcare by developing its new pharmacy degree.

Regulation and quality control for the medical cannabis industry

AlphaCAT (Cannabinoid Analysis Test) takes the first step to regulation and quality control for the medical cannabis industry, as this profile by the firm’s Sebastien Beguerie sheds light on.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders